Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: DCTD[original query] |
---|
An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients. The oncologist 2007 Jun 12 (6): 622-30. Rha Sun Young, Jeung Hei Cheul, Choi Yeon Ho, Yang Woo Ick, Yoo Jin Ho, Kim Byung Soo, Roh Jae Kyung, Chung Hyun Che |
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jan 16 (1): 320-9. Okazaki Taro, Javle Milind, Tanaka Motofumi, Abbruzzese James L, Li Dongh |
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer. Cancer 2010 Nov 116 (22): 5325-35. Tanaka Motofumi, Javle Milind, Dong Xiaoqun, Eng Cathy, Abbruzzese James L, Li Dongh |
A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP. International journal of cancer. Journal international du cancer 2011 Oct 129 (7): 1689-98. Harlid Sophia, Ivarsson Malin I L, Butt Salma, Hussain Shehnaz, Grzybowska Ewa, Eyfjörd Jorunn Erla, Lenner Per, Försti Asta, Hemminki Kari, Manjer Jonas, Dillner Joakim, Carlson Joy |
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy. European journal of cancer (Oxford, England : 1990) 2011 Apr 47 (6): 839-47. Rodriguez J, Boni V, Hernández A, Bitarte N, Zarate R, Ponz-Sarvisé M, Chopitea A, Bandres E, Garcia-Foncillas |
Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine. Pharmacogenomics 2012 Jul 13 (9): 9. Woo HI, Kim KK, Choi H, Kim S, Jang KT, Yi JH, Park YS, Park JO, Lee SY |
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors. Pharmacogenomics 2012 Jul 13 (9): 9. Mitra AK, Kirstein MN, Khatri A, Skubitz KM, Dudek AZ, Greeno EW, Kratzke RA, Lamba JK |
Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy. International journal of hematology 2015 Mar . Amaki Jun, Onizuka Makoto, Ohmachi Ken, Aoyama Yasuyuki, Hara Ryujiro, Ichiki Akifumi, Kawai Hidetsugu, Sato Ai, Miyamoto Mitsuki, Toyosaki Masako, Machida Shinichiro, Kojima Minoru, Shirasugi Yukari, Kawada Hiroshi, Ogawa Yoshiaki, Ando Kiyos |
Pathway, in silico and tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data. International journal of epidemiology 2015 Dec . Hyland Paula L, Zhang Han, Yang Qi, Yang Howard H, Hu Nan, Lin Shih-Wen, Su Hua, Wang Lemin, Wang Chaoyu, Ding Ti, Fan Jin-Hu, Qiao You-Lin, Sung Hyuna, Wheeler William, Giffen Carol, Burdett Laurie, Wang Zhaoming, Lee Maxwell P, Chanock Stephen J, Dawsey Sanford M, Freedman Neal D, Abnet Christian C, Goldstein Alisa M, Yu Kai, Taylor Philip |
Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia. Pediatric blood & cancer 2015 Apr 62 (4): 622-8. Gabor Krisztina Mita, Schermann Geza, Lautner-Csorba Orsolya, Rarosi Ferenc, Erdelyi Daniel J, Endreffy Emoke, Berek Krisztina, Bartyik Katalin, Bereczki Csaba, Szalai Csaba, Semsei Agnes |
Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients. Journal of translational medicine 2017 Nov 15 (1): 235. Cao Hai-Xia, Miao Chao-Feng, Yan Liang, Tang Ping, Zhang Li-Rong, Sun Li |
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance).
Pharmacogenetics and genomics 2019 Mar . Innocenti Federico, Jiang Chen, Sibley Alexander B, Denning Stefanie, Etheridge Amy S, Watson Dorothy, Niedzwiecki Donna, Hatch Ace J, Hurwitz Herbert I, Nixon Andrew B, Furukawa Yoichi, Kubo Michiaki, Crona Daniel J, Kindler Hedy L, McLeod Howard L, Ratain Mark J, Owzar Kour |
Gene-Gene Interactions of Gemcitabine Metabolizing-Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine-Induced Hematological Toxicity. Journal of clinical pharmacology 2021 5 61 (10): 1376-1385. Li Juan, Chen Bing, Xi Wen-Qi, Yang Chen, Zhang Wei-X |
HLA-DRB1 Polymorphisms and Rheumatologic Manifestations in Chronic Hepatitis C. Current rheumatology reviews 2022 6 19 (1): 58-63. Medolago Natália Bronzatto, Ferrasi Adriana Camargo, da Rocha Oswaldo Melo, de Moura Campos Pardini Maria Inês, Tommasini Grotto Rejane Maria, Silva Giovanni Far |
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: